Clin2
NCT06476704Possibly a fitNot yet recruiting

Radiation plus study drug before surgery for soft tissue sarcoma

Sarcoma

Part of Cancer clinical trials.

This trial tests whether adding a study drug called liposomal transcrocetin to radiation therapy before surgery improves outcomes for adults with soft tissue sarcoma in the arm or leg. The goal is to see if the combination is safe and effective.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
42 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a soft tissue sarcoma in your arm or leg that has not spread and can be surgically removed.
  • Your tumor is grade 2 or 3 (more aggressive).
  • You are scheduled to have radiation and surgery as part of your care.
  • You are in generally good health (able to care for yourself) and expected to live at least 6 more months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07071727Recruiting
Short course of radiation before surgery for soft tissue sarcoma

This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.

Amsterdam
NCT07501026Recruiting· Phase 2
Testing a new radiation method before sarcoma surgery

This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.

Hangzhou, Zhejiang
NCT04307277Recruiting· Phase 3
Chemotherapy before and after surgery for high-risk soft tissue sarcoma

This trial tests whether giving chemotherapy both before and after surgery helps people with high-risk soft tissue sarcoma live longer and prevents the cancer from coming back. It aims to see if this treatment plan is more effective than surgery alone.

Besançon
NCT06835049Recruiting· Phase 2
Heating therapy before surgery for high-risk soft tissue sarcoma

This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.

Aarau
NCT07612098Not yet recruiting· Phase 2
Radiation and drug combo before surgery for soft tissue sarcoma

This trial tests a combination of radiation therapy and two drugs (anlotinib and penpulimab) given before surgery for soft tissue sarcoma. The goal is to see if this approach can shrink tumors and improve outcomes.

Beijing, Beijing Municipality
NCT07507773Recruiting· Phase 2
Radiation before surgery for limb or trunk wall sarcoma

This trial tests a shorter course of radiation given before surgery for soft tissue sarcoma in the arms, legs, or trunk wall. It aims to see if this approach works well long-term and may help you keep your limb.

Lille

Hear when a new Sarcoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.